Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27682088)

Published in Microorganisms on May 20, 2015

Authors

Tim Downing1

Author Affiliations

1: School of Biotechnology, Faculty of Science and Health, Dublin City University, Dublin 9, Ireland. tim.downing@dcu.ie.

Articles cited by this

(truncated to the top 100)

Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82

Stochastic gene expression in a single cell. Science (2002) 34.54

Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods (2013) 31.15

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother (2009) 16.90

Bacterial persistence as a phenotypic switch. Science (2004) 15.80

Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science (2010) 11.37

An approximately unbiased test of phylogenetic tree selection. Syst Biol (2002) 11.00

High mutation frequencies among Escherichia coli and Salmonella pathogens. Science (1996) 10.88

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med (2011) 9.37

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med (2011) 8.55

Phenotypic diversity, population growth, and information in fluctuating environments. Science (2005) 8.21

The CTX-M beta-lactamase pandemic. Curr Opin Microbiol (2006) 8.08

Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med (2011) 7.35

Updated functional classification of beta-lactamases. Antimicrob Agents Chemother (2009) 7.16

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One (2011) 6.75

Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis (2012) 6.64

The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol (2008) 6.02

The accumulation of deleterious genes in a population--Muller's Ratchet. Theor Popul Biol (1978) 5.51

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother (2010) 5.35

Consequences of recombination on traditional phylogenetic analysis. Genetics (2000) 5.01

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis (2010) 4.98

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA (1999) 4.69

hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol (1983) 4.59

Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis (2000) 4.40

The epidemiology of urinary tract infection. Nat Rev Urol (2010) 3.97

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol (2006) 3.96

A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93

Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog (2011) 3.89

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother (2009) 3.79

Gene regulatory network growth by duplication. Nat Genet (2004) 3.79

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents (2010) 3.77

Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol (2014) 3.75

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69

Growth rate-dependent global effects on gene expression in bacteria. Cell (2009) 3.57

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56

A reference bacterial genome dataset generated on the MinION™ portable single-molecule nanopore sequencer. Gigascience (2014) 3.52

Using gene expression noise to understand gene regulation. Science (2012) 3.49

Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov (2006) 3.40

Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing. Nat Biotechnol (2012) 3.39

Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29

Stochastic modelling for quantitative description of heterogeneous biological systems. Nat Rev Genet (2009) 3.27

Comparative ICE genomics: insights into the evolution of the SXT/R391 family of ICEs. PLoS Genet (2009) 2.91

Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med (2014) 2.87

Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet (2011) 2.86

Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol (2008) 2.81

A predictive fitness model for influenza. Nature (2014) 2.73

Multilocus variable-number tandem repeat analysis distinguishes outbreak and sporadic Escherichia coli O157:H7 isolates. J Clin Microbiol (2003) 2.69

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother (2008) 2.66

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64

New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India (2010) 2.60

Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat Genet (2013) 2.59

Horizontal transfer, not duplication, drives the expansion of protein families in prokaryotes. PLoS Genet (2011) 2.54

Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med (2013) 2.52

Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother (2003) 2.51

Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol (2007) 2.44

Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol Biol Evol (2007) 2.34

The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother (2012) 2.33

Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol (2004) 2.29

Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control (2013) 2.29

Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev (2014) 2.26

Real-time evolution of new genes by innovation, amplification, and divergence. Science (2012) 2.22

Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis (2010) 2.22

Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A (2014) 2.20

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17

Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J Antimicrob Chemother (2000) 2.15

Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect (2008) 2.11

UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother (2008) 2.08

Control of carbon flux to acetate excretion during growth of Escherichia coli in batch and continuous cultures. J Gen Microbiol (1989) 2.08

Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol (2008) 2.06

Cryptic prophages help bacteria cope with adverse environments. Nat Commun (2010) 2.05

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis (2012) 2.05

Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet (2009) 2.02

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance. Front Microbiol (2012) 1.98

Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One (2011) 1.94

Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One (2012) 1.91

Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother (2009) 1.91

Prophage excision activates Listeria competence genes that promote phagosomal escape and virulence. Cell (2012) 1.87

Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science (2011) 1.87

Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol (2005) 1.84

Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. BMJ (2014) 1.84

What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol (2011) 1.83

Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother (2011) 1.82

Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci U S A (2014) 1.82

Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother (2010) 1.79

Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J Antimicrob Chemother (1997) 1.78

Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother (2009) 1.75

Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol (2013) 1.72

Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. J Clin Microbiol (2013) 1.71

Robust control of nitrogen assimilation by a bifunctional enzyme in E. coli. Mol Cell (2011) 1.70

Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells. Nat Biotechnol (2013) 1.69

Rapid single-colony whole-genome sequencing of bacterial pathogens. J Antimicrob Chemother (2013) 1.66

Resolution of gene regulatory conflicts caused by combinations of antibiotics. Mol Cell (2011) 1.65

Regulation of glycogen metabolism in yeast and bacteria. FEMS Microbiol Rev (2010) 1.64

Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother (2011) 1.63

Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother (2013) 1.61

Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother (2012) 1.60

Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates. Environ Microbiol (2006) 1.58

Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev (2011) 1.58

(Patho-)Genomics of Escherichia coli. Int J Med Microbiol (2005) 1.50

Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap! Clin Infect Dis (2010) 1.48